Specifically, as shown in Table 2, expression of IDO1 was low in majority (92.5%, 37/40) of stage I lung adenocarcinomas, with only 7.5% (3/40) of stage I tissues showed highly expressed IDO1 (P < 0.01). This evidence concerns the gene IDO1 and lung adenocarcinoma.